319 related articles for article (PubMed ID: 36123627)
21. Ubiquitin specific peptidase 19 is a prognostic biomarker and affect the proliferation and migration of clear cell renal cell carcinoma.
Hu W; Su Y; Fei X; Wang X; Zhang G; Su C; Du T; Yang T; Wang G; Tang Z; Zhang J
Oncol Rep; 2020 Jun; 43(6):1964-1974. PubMed ID: 32236633
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation-mediated low expression of ZNF582 promotes the proliferation, migration, and invasion of clear cell renal cell carcinoma.
Ding M; Wang Q; Zhu W; Chang J; Liao H; Xiao G
Clin Exp Nephrol; 2023 Jan; 27(1):24-31. PubMed ID: 36129555
[TBL] [Abstract][Full Text] [Related]
23. High VSX1 expression promotes the aggressiveness of clear cell renal cell carcinoma by transcriptionally regulating FKBP10.
Ma W; Li X; Yang L; Pan J; Chen Y; Lu Y; Dong X; Li D; Gan W
J Transl Med; 2022 Dec; 20(1):554. PubMed ID: 36463181
[TBL] [Abstract][Full Text] [Related]
24. [Mechanism of nuclear protein 1 in the resistance to axitinib in clear cell renal cell carcinoma].
Liu YC; Wu ZL; Ge LY; DU T; Wu YQ; Song YM; Liu C; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Oct; 55(5):781-792. PubMed ID: 37807730
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-30a-5p Inhibits the Growth of Renal Cell Carcinoma by Modulating GRP78 Expression.
Wang C; Cai L; Liu J; Wang G; Li H; Wang X; Xu W; Ren M; Feng L; Liu P; Zhang C
Cell Physiol Biochem; 2017; 43(6):2405-2419. PubMed ID: 29073630
[TBL] [Abstract][Full Text] [Related]
26. TMSB10 acts as a biomarker and promotes progression of clear cell renal cell carcinoma.
Pan Q; Cheng G; Liu Y; Xu T; Zhang H; Li B
Int J Oncol; 2020 May; 56(5):1101-1114. PubMed ID: 32319572
[TBL] [Abstract][Full Text] [Related]
27. PBRM1 mutation and WDR72 expression as potential combinatorial biomarker for predicting the response to Nivolumab in patients with ccRCC: a tumor marker prognostic study.
Chang Q; Sun J; Zhao S; Li L; Zhang N; Yan L; Fan Y; Liu J
Aging (Albany NY); 2023 Nov; 15(23):13753-13775. PubMed ID: 38048211
[TBL] [Abstract][Full Text] [Related]
28. Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.
Xue S; Guo H; Wei S; Song Y; Huang J; Deng S; Li Q; Li W
Transl Androl Urol; 2022 Sep; 11(9):1304-1317. PubMed ID: 36217399
[TBL] [Abstract][Full Text] [Related]
29. Multi-Omics Analysis of the Expression and Prognosis for FKBP Gene Family in Renal Cancer.
Sun Z; Qin X; Fang J; Tang Y; Fan Y
Front Oncol; 2021; 11():697534. PubMed ID: 34476212
[TBL] [Abstract][Full Text] [Related]
30. TRIM33 Overexpression Inhibits the Progression of Clear Cell Renal Cell Carcinoma In Vivo and In Vitro.
Xu Y; Wu G; Zhang J; Li J; Ruan N; Zhang J; Zhang Z; Chen Y; Zhang Q; Xia Q
Biomed Res Int; 2020; 2020():8409239. PubMed ID: 32908919
[TBL] [Abstract][Full Text] [Related]
31. POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.
Tian J; Cheng C; Gao J; Fu G; Xu Z; Chen X; Wu Y; Jin B
Int J Mol Sci; 2023 Apr; 24(7):. PubMed ID: 37047824
[TBL] [Abstract][Full Text] [Related]
32. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of CENPM is associated with poor clinical outcome and suppression of immune profile in clear cell renal cell carcinoma.
Zhang ZC; Liu YF; Xi P; Nie YC; Sun T; Gong BB
Hereditas; 2023 Jan; 160(1):1. PubMed ID: 36635779
[TBL] [Abstract][Full Text] [Related]
34. Bioinformatics analysis and verification of gene targets for renal clear cell carcinoma.
Li F; Jin Y; Pei X; Guo P; Dong K; Wang H; Chen Y; Guo P; Meng LB; Wang Z
Comput Biol Chem; 2021 Jun; 92():107453. PubMed ID: 33636636
[TBL] [Abstract][Full Text] [Related]
35. Identification and validation of prognostic and tumor microenvironment characteristics of necroptosis index and BIRC3 in clear cell renal cell carcinoma.
Wei K; Zhang X; Yang D
PeerJ; 2023; 11():e16643. PubMed ID: 38130918
[TBL] [Abstract][Full Text] [Related]
36. The value of EYA1/3/4 in clear cell renal cell carcinoma: a study from multiple databases.
Liu T; Nie J; Zhang X; Deng X; Fu B
Sci Rep; 2023 May; 13(1):7442. PubMed ID: 37156847
[TBL] [Abstract][Full Text] [Related]
37. KIF2C promotes clear cell renal cell carcinoma progression via activating JAK2/STAT3 signaling pathway.
Deng H; Gong X; Ji G; Li C; Cheng S
Mol Cell Probes; 2023 Dec; 72():101938. PubMed ID: 37863123
[TBL] [Abstract][Full Text] [Related]
38. A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.
Meng W; Chen B; Jiang Z; Cai B; Ma L; Guan Y
Transl Cancer Res; 2023 Aug; 12(8):2071-2098. PubMed ID: 37701098
[TBL] [Abstract][Full Text] [Related]
39. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
40. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
